Moreover, the complex interplay between MMPs and TIMPs adds another layer of regulatory complexity, where the balance between MMP-9 and TIMP-1 has been shown to influence glioma invasiveness, with higher TIMP-1 levels correlating with reduced MMP-9 activity and, consequently, reduced tumor invasion [151]. The gene discussed is TIMP1; the disease is central nervous system cancer.